Skip to main content
. 2024 Sep 15;14(9):4113–4171. doi: 10.62347/UJVP4361

Figure 2.

Figure 2

The correlation between the dysregulation of other signaling pathways and lenvatinib resistance. The dysregulation of lipid metabolism, wnt/β-catenin signaling, hippo signaling, notch signaling, hedgehog signaling, RNA modifications and ferroptosis was found to participate the regulation of LEN resistance in uHCC treatment. And, a series of proteins and a range of drugs acted on corresponding targets to play roles in promoting or inhibiting LEN resistance in HCC treatment.